Msp Recovery Inc (LIFW)

$0.713

-0.01

(-0.97%)▲

Market is closed - opens 7 PM, 23 May 2024

Insights on Msp Recovery Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 440.0K → 6.00M (in $), with an average increase of 63.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -23.45M → -18.88M (in $), with an average increase of 24.2% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 35.6% return, outperforming this stock by 130.1%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 1.5% return, outperforming this stock by 94.2%

Performance

  • $0.69
    $0.73
    $0.71
    downward going graph

    2.12%

    Downside

    Day's Volatility :4.8%

    Upside

    2.74%

    downward going graph
  • $0.65
    $16.75
    $0.71
    downward going graph

    8.44%

    Downside

    52 Weeks Volatility :96.12%

    Upside

    95.76%

    downward going graph

Returns

PeriodMsp Recovery IncIndex (Russel 2000)
3 Months
-12.44%
0.0%
6 Months
-85.91%
0.0%
1 Year
-94.46%
0.0%
3 Years
-92.66%
-20.1%

Highlights

Market Capitalization
99.6M
Book Value
$18.58
Earnings Per Share (EPS)
-6.32
Wall Street Target Price
3.0
Profit Margin
0.0%
Operating Margin TTM
-2479.42%
Return On Assets TTM
-10.64%
Return On Equity TTM
-46.34%
Revenue TTM
7.7M
Revenue Per Share TTM
0.86
Quarterly Revenue Growth YOY
309.1%
Gross Profit TTM
14.4M
EBITDA
-83.1M
Diluted Eps TTM
-6.32
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Msp Recovery Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 320.76%

Current $0.71
Target $3.00

Company Financials

FY20Y/Y Change
Revenue
13.9M
-
Net Income
-24.2M
-
Net Profit Margin
-174.61%
-
FY21Y/Y Change
Revenue
14.6M
↑ 5.32%
Net Income
-33.1M
↑ 36.48%
Net Profit Margin
-226.26%
↓ 51.65%
FY22Y/Y Change
Revenue
23.4M
↑ 60.13%
Net Income
-7.4M
↓ 77.59%
Net Profit Margin
-31.67%
↑ 194.59%
FY23Y/Y Change
Revenue
7.7M
↓ 67.1%
Net Income
-56.3M
↑ 659.71%
Net Profit Margin
-731.32%
↓ 699.65%
Q4 FY22Q/Q Change
Revenue
1.6M
↓ 80.45%
Net Income
-5.7M
↑ 1123.76%
Net Profit Margin
-348.46%
↓ 342.89%
Q1 FY23Q/Q Change
Revenue
4.0M
↑ 145.69%
Net Income
-4.9M
↓ 13.24%
Net Profit Margin
-123.05%
↑ 225.41%
Q2 FY23Q/Q Change
Revenue
2.5M
↓ 36.37%
Net Income
-8.2M
↑ 67.21%
Net Profit Margin
-323.37%
↓ 200.32%
Q3 FY23Q/Q Change
Revenue
440.0K
↓ 82.69%
Net Income
-19.8M
↑ 140.33%
Net Profit Margin
-4.5K%
↓ 4166.4%
Q4 FY23Q/Q Change
Revenue
728.0K
↑ 65.45%
Net Income
-23.5M
↑ 18.74%
Net Profit Margin
-3.2K%
↑ 1267.65%
Q1 FY24Q/Q Change
Revenue
6.0M
↑ 724.31%
Net Income
-18.9M
↓ 19.5%
Net Profit Margin
-314.65%
↑ 2907.47%
FY20Y/Y Change
Total Assets
17.8M
-
Total Liabilities
133.7M
-
FY21Y/Y Change
Total Assets
104.0M
↑ 482.9%
Total Liabilities
255.4M
↑ 91.05%
FY22Y/Y Change
Total Assets
3.4B
↑ 3186.3%
Total Liabilities
1.2B
↑ 381.83%
FY23Y/Y Change
Total Assets
3.2B
↓ 7.55%
Total Liabilities
1.7B
↑ 41.46%
Q4 FY22Q/Q Change
Total Assets
3.4B
↓ 48.01%
Total Liabilities
1.2B
↑ 4.2%
Q1 FY23Q/Q Change
Total Assets
3.5B
↑ 3.86%
Total Liabilities
1.5B
↑ 24.83%
Q2 FY23Q/Q Change
Total Assets
3.4B
↓ 3.92%
Total Liabilities
1.6B
↑ 4.61%
Q3 FY23Q/Q Change
Total Assets
3.3B
↓ 3.77%
Total Liabilities
1.6B
↑ 1.95%
Q4 FY23Q/Q Change
Total Assets
3.2B
↓ 3.72%
Total Liabilities
1.7B
↑ 6.26%
Q1 FY24Q/Q Change
Total Assets
3.0B
↓ 3.91%
Total Liabilities
1.8B
↑ 2.98%
FY20Y/Y Change
Operating Cash Flow
-14.0K
-
Investing Cash Flow
986.0K
-
Financing Cash Flow
9.6M
-
FY21Y/Y Change
Operating Cash Flow
2.2M
↓ 16164.29%
Investing Cash Flow
-2.0M
↓ 303.55%
Financing Cash Flow
-10.5M
↓ 208.81%
Q4 FY22Q/Q Change
Operating Cash Flow
-9.9M
↑ 0.19%
Investing Cash Flow
50.0K
↓ 103.23%
Financing Cash Flow
384.0K
↓ 38.36%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.0M
↑ 1.06%
Investing Cash Flow
50.0K
↑ 0.0%
Financing Cash Flow
8.4M
↑ 2088.8%
Q2 FY23Q/Q Change
Operating Cash Flow
-14.6M
↑ 46.6%
Investing Cash Flow
8.1M
↑ 16046.0%
Financing Cash Flow
-575.0K
↓ 106.84%

Technicals Summary

Sell

Neutral

Buy

Msp Recovery Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Msp Recovery Inc
Msp Recovery Inc
-40.98%
-85.91%
-94.46%
-92.66%
-92.48%
Solventum Corp
Solventum Corp
-1.37%
-11.4%
-11.4%
-11.4%
-11.4%
Veeva Systems Inc.
Veeva Systems Inc.
5.11%
19.08%
26.56%
-20.38%
44.87%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-2.81%
11.33%
3.62%
35.46%
35.46%
Healthequity Inc
Healthequity Inc
-2.32%
18.78%
35.6%
2.03%
13.46%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Msp Recovery Inc
Msp Recovery Inc
3.59
NA
NA
0.0
-0.46
-0.11
NA
18.58
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
65.41
65.41
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.71
23.71
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
124.06
124.06
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Msp Recovery Inc
Msp Recovery Inc
Buy
$99.6M
-92.48%
3.59
0.0%
Solventum Corp
Solventum Corp
NA
$10.8B
-11.4%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$33.9B
44.87%
65.41
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$37.2B
35.46%
23.71
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
13.46%
124.06
5.57%

Company Information

msp recovery uses a multi-level structure involving proprietary software and a highly trained staff including it personnel, accountants, statisticians, physicians, data analysts and attorneys to maximize the recovery of claims already paid. msp recovery conducts an analysis to determine which paid claims the health plans, management service organizations, providers of medical services and independent physician associations were not financially responsible for. taking a proactive role in data analytics, msp recovery seeks to find all the paid claims which should have been paid by another payer. the statute of limitations for most claims allows us to recover as far back as 6 years on our clients’ behalf. these efforts establish the basis for msp recovery law firm to shift the burden from the secondary payer (health plan, aco or ipa) to the primary payer (auto insurance, general liability insurance, workers compensation, product liability carriers, etc.). msp recovery law firm focuses o

Organization
Msp Recovery Inc
Employees
88
CEO
Mr. John H. Ruiz
Industry
Financial

Discover More

FAQs